EXPERT SPEAKER FACULTY

Archana Belle

Vice President - Translational Research

Encoded Therapeutics

Ben Deverman

Director - Vector Engineering at the Stanley Center for Psychiatric Research

The Broad Institute

Darin Falk

Vice President, Discovery and Early Preclinical Development

Neurogene

David Margolin

Vice President - Clinical Development

uniQure

David Ojala

Director, AAV Engineering

Sangamo Therapeutics

Don Haut

Chief Business Officer

EG427

Eric Kelsic

Co Founder & Chief Executive Officer

Dyno Therapeutics

Frederic Padilla

Director of the Gene and Cell Therapy Program

Focused Ultrasound Foundation

Isabelle Aubert

Senior Scientist

Sunnybrook Research Institute

Ivelisse Sanchez

Founder & CSO

Biointaxis

Jang-Ho Cha

CSO

Latus Bio

Jennifer Johnston

CEO

Nysno Bio

Joe La Barge

CEO

Apertura Gene Therapy

John Reece-Hoyes

Senior Director - Head of Vector Biology

Affinia Therapeutics

Kathryn Allaway

Head of R&D

Regel Therapeutics

Laura Pisani

Senior Director - Medical & Clinical Development Lead CNS Rare

REGENXBIO

Massimo Fiandaca

Executive Vice President - Therapeutic Strategies, CNS Gene Therapy

AskBio

Melvin Rincon

Principal Scientist - Gene Therapy

UCB

Perry Spratt

Program Director - In Vivo Preclinical Programs

Regel Therapeutics

Peter Ghoroghchian

Chief Executive Officer

Latus Bio

Samir Koirala

Senior Director

Biogen

Teddy Jegu

Director of Research

EG427